黃河實業(00318.HK)中期純利升12.65%至1408.7萬港元
格隆匯12月31日丨黃河實業(00318.HK)公佈,截至2021年10月31日止六個月,公司營業額為9185.7萬港元,同比增長93.21%;公司擁有人應占期間溢利為1408.7萬港元,同比增長12.65%,基本每股盈利為0.064港元。
基於集團過去幾年的穩定增長,公司作為商業科技服務和解決方案提供商的主營業務亦實現增長,尤其是,主要專注於金融科技、電子商務、支付、雲端科技和企業解決方案的業務。
截至2021年10月31日止六個月,集團的收入和利潤與去年同期相比有了顯著增長。因新冠疫情"新常態"期間的經濟中斷而令科技和大數據的數碼化轉型的趨勢加速了該業務增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.